Provided by Tiger Trade Technology Pte. Ltd.

Denali Therapeutics Inc.

24.92
-0.0300-0.12%
Post-market: 24.920.00000.00%19:30 EDT
Volume:680.99K
Turnover:16.96M
Market Cap:3.98B
PE:-8.79
High:25.37
Open:25.25
Low:24.60
Close:24.95
52wk High:27.30
52wk Low:12.58
Shares:159.85M
Float Shares:151.07M
Volume Ratio:0.67
T/O Rate:0.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8353
EPS(LYR):-2.9700
ROE:-54.93%
ROA:-29.15%
PB:4.77
PE(LYR):-8.39

Loading ...

Biogen - Phase 2B Luma Study of Biib122 Does Not Meet Primary or Secondary Endpoints

THOMSON REUTERS
·
May 22

Biogen - Co and Denali to Discontinue Development of Biib122 in Idiopathic Parkinson’s Disease

THOMSON REUTERS
·
May 22

Denali Therapeutics trading halted, news pending

TIPRANKS
·
May 22

NASDAQ TRADE HALT HALT NEWS PENDING AT 05:55 PM

Reuters
·
May 22

Stock Track | Denali Therapeutics Soars 7.98% Pre-market on Sector Optimism After Biogen's Alzheimer's Therapy Advancement

Stock Track
·
May 14

BUZZ-Biogen climbs on plans to advance development of experimental Alzheimer's therapy

Reuters
·
May 14

Denali Therapeutics Seeing Encouraging Signals From Avlayah Launch, Oppenheimer Says

MT Newswires Live
·
May 11

Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Definitive Healthcare Corp (DH) and Denali Therapeutics (DNLI)

TIPRANKS
·
May 11

Denali Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Denali Therapeutics Q1 net loss narrows as expenses fall

Reuters
·
May 08

BRIEF-Denali Therapeutics Q1 Operating Expenses USD 137.357 Million

Reuters
·
May 08

Denali Therapeutics Q1 Net Income USD -128.447 Million

THOMSON REUTERS
·
May 08

Denali Therapeutics (DNLI) Is Down 6.4% After Takeda Exits DNL593 Partnership - What's Changed

Simply Wall St.
·
May 05

Denali Therapeutics announces annual shareholder meeting via webcast

Reuters
·
Apr 22

Denali Therapeutics CMO Peter Scott Chin files initial beneficial ownership statement

Reuters
·
Apr 21

US FDA's accelerated approval for drugs needs more transparency, says research firm

Reuters
·
Apr 16

How AVLAYAH’s Accelerated Approval and Takeda Exit Will Impact Denali Therapeutics (DNLI) Investors

Simply Wall St.
·
Apr 08

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Norfolk Southern, Denali

Reuters
·
Apr 07

Denali Therapeutics Regains Full Rights to Dementia Drug Following Takeda Partnership Termination

MT Newswires Live
·
Apr 06

Denali Therapeutics regains full rights to DNL593

TIPRANKS
·
Apr 06